PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 68 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 5.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $40,770 | +106.7% | 16,051 | +52.1% | 0.00% | – |
| Q4 2022 | $19,729 | -63.5% | 10,550 | -42.1% | 0.00% | – |
| Q1 2022 | $54,000 | -31.6% | 18,211 | +4.4% | 0.00% | – |
| Q4 2021 | $79,000 | -12.2% | 17,446 | -5.6% | 0.00% | – |
| Q3 2021 | $90,000 | -9.1% | 18,484 | +27.2% | 0.00% | – |
| Q2 2021 | $99,000 | -87.2% | 14,534 | -89.8% | 0.00% | – |
| Q3 2020 | $771,000 | -79.9% | 142,486 | -6.7% | 0.00% | -100.0% |
| Q3 2017 | $3,834,000 | -53.8% | 152,754 | -55.6% | 0.00% | -66.7% |
| Q2 2017 | $8,300,000 | +22955.6% | 344,399 | +24239.2% | 0.00% | – |
| Q2 2015 | $36,000 | – | 1,415 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,138,872 | $55,119,000 | 27.83% |
| Abingworth LLP | 1,301,413 | $33,524,000 | 15.22% |
| Roumell Asset Management, LLC | 207,703 | $5,353,000 | 9.43% |
| GREAT POINT PARTNERS LLC | 415,338 | $10,703,000 | 4.17% |
| Aisling Capital LLC | 682,680 | $17,593,000 | 2.62% |
| Broadfin Capital, LLC | 530,283 | $13,665,000 | 0.73% |
| Baupost Group | 1,544,498 | $39,802,000 | 0.66% |
| Tekla Capital Management LLC | 691,000 | $17,807,000 | 0.64% |
| GENERAL AMERICAN INVESTORS CO INC | 277,076 | $7,140,000 | 0.59% |
| Lombard Odier Asset Management (USA) Corp | 140,000 | $3,607,000 | 0.26% |